Maccura Biotechnology Co., Ltd. (300463) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Maccura Biotechnology Co., Ltd.

Why is Maccura Biotechnology Co., Ltd. ?

Poor long term growth as Net Sales has grown by an annual rate of -12.85% and Operating profit at -157.53% over the last 5 years

The company has declared Negative results for the last 6 consecutive quarters

OPERATING CASH FLOW(Y) Lowest at CNY 685.05 MM
NET PROFIT(9M) At CNY -60.33 MM has Grown at -31.48%
INTEREST(HY) At CNY 12.94 MM has Grown at 13%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -27.27%, its profits have fallen by -333.3%
At the current price, the company has a high dividend yield of 0

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -27.27% returns in the last 1 year, the stock has also underperformed China Shanghai Composite in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Maccura Biotechnology Co., Ltd. for you?

Medium Risk, Low Return

Absolute

Risk Adjusted

Volatility

Maccura Biotechnology Co., Ltd.

-100.0%

-0.92

30.84%

China Shanghai Composite

8.25%

1.20

14.07%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

-12.85%

EBIT Growth (5y)

-157.53%

EBIT to Interest (avg)

9.02

Debt to EBITDA (avg)

0.23

Net Debt to Equity (avg)

0.02

Sales to Capital Employed (avg)

0.33

Tax Ratio

56.33%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

6.73%

ROE (avg)

11.25%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.78

EV to EBIT

-62.74

EV to EBITDA

24.94

EV to Capital Employed

0.79

EV to Sales

2.40

PEG Ratio

Dividend Yield

ROCE (Latest)

-1.26%

ROE (Latest)

-0.95%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

Mildly Bearish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

15What is working for the Company

OPERATING CASH FLOW(Y)

Highest at CNY 741.15 MM

PRE-TAX PROFIT(Q)

Highest at CNY 8.81 MM

NET PROFIT(Q)

Highest at CNY 25.42 MM

EPS(Q)

Highest at CNY 0.04

-8What is not working for the Company

INTEREST(HY)

At CNY 13.04 MM has Grown at 25.35%

RAW MATERIAL COST(Y)

Grown by 9.45% (YoY

INVENTORY TURNOVER RATIO(HY)

Lowest at 1.33 times

Here's what is working for Maccura Biotechnology Co., Ltd.

Net Profit

At CNY 25.42 MM has Grown at 302.53%

over average net sales of the previous four periods of CNY -12.55 MM

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (CNY MM)

Pre-Tax Profit

At CNY 8.81 MM has Grown at 129.38%

over average net sales of the previous four periods of CNY -29.98 MM

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (CNY MM)

Operating Cash Flow

Highest at CNY 741.15 MM

in the last three years

MOJO Watch

The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Pre-Tax Profit

Highest at CNY 8.81 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (CNY MM)

Net Profit

Highest at CNY 25.42 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (CNY MM)

EPS

Highest at CNY 0.04

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (CNY)

Here's what is not working for Maccura Biotechnology Co., Ltd.

Interest

At CNY 13.04 MM has Grown at 25.35%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Inventory Turnover Ratio

Lowest at 1.33 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling inventory has slowed

Inventory Turnover Ratio

Raw Material Cost

Grown by 9.45% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales